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Background
U.S. incidence rates of anal cancer have increased stea-
dily over time, and are generally higher in women than
men. It has been proposed that the HIV epidemic may
have influenced U.S. anal cancer trends. Compared to
the general population, anal cancer rates are strongly
elevated in HIV-infected individuals. Anal cancer rates
in HIV-infected individuals have also increased over
time. We estimated the impact of the HIV epidemic on
U.S. anal cancer trends during 1980-2007.
Methods
Data on anal cancer incidence rates were obtained from
the HIV/AIDS Cancer Match Study, which links 14 U.S.
HIV/AIDS and cancer registries. We estimated inci-
dence rates with anal cancer cases and person-years for
the general population, and then subtracted 2 groups of
cases in people with AIDS: cases that occurred after
AIDS diagnosis (incident) and within 5 years prior to
AIDS (prevalent). All rates were standardized to the
2000 U.S. population by age, sex and race. Poisson
regression was used to estimate changes in rates over
time.
Results
During 1980-2007, a total of 25,011 anal cancers
occurred in 2.1 billion person-years of follow-up. Of
these, 1087 were incident and 456 were prevalent cases
in people with AIDS. Among men, the anal cancer rate
increased 2.0% per year from 0.69 to 1.06/100,000 during
1980-2007 (Figure 1A). Excluding cases in people with
AIDS, the rate only increased 0.77% per year to 0.77/
100,000 in 2007. Among women, the anal cancer rate
increased 2.1% per year from 1.09 to 1.71/100,000 during
1980-2007 (Figure 1B). Removal of cases with AIDS
changed the trends very little (increase of 2.1% per year).
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Figure 1 Male (A) and female (B) anal cancer incidence rates in overall (black line), excluding incident cases in people with AIDS (blue line), and
excluding incident and prevalent cases in people with AIDS (red line), 1980-2007.
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trends in men. Overall rates increased 4.0% per year, but
r a t e se x c l u d i n gA I D Sc a s e si n c r e a s e do n l y0 . 7 2 %p e r
year. In contrast, among women aged 20-49 years, AIDS
had little impact on annual anal cancer rates (3.7% over-
all vs. 3.4% excluding AIDS cases). In 70+ year olds, the
age group with the highest anal cancer incidence, AIDS
had a small effect on male and no effect on female trends.
During 2003-2007, 24.2% of anal cancers among men and
1.6% among women occurred in people with AIDS.
Conclusions
During 1980-2007, the U.S. anal cancer epidemic in young
men was strongly influenced by the HIV epidemic;
however, among women, the anal cancer epidemic was
independent of HIV. Effective anal cancer prevention in
HIV-infected men would have a substantial impact on
U.S. anal cancer rates.
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